Known targets — ChEMBL curated mechanism
CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 5/20 | 0.42 |
| ▸ | CHRM3 known ✓ | P20309 | 5/20 | 0.42 |
| ▸ | CHRM5 known ✓ | P08912 | 3/20 | 0.42 |
| ▸ | CHRM2 known ✓ | P08172 | 4/20 | 0.40 |
| ▸ | CHRM4 known ✓ | P08173 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.40 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GALR3 | O60755 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16592437 | 0.92 | CA1 (0.37) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| SCHEMBL16592455 | 0.92 | THRB (0.42) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| SCHEMBL649844 | 0.90 | CHRM1 (0.40) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| SCHEMBL1403451 | 0.90 | LMNA (0.44) | SMN1; SMN2CA1CA2HTTAPEX1 | |
| SCHEMBL1262971 | 0.89 | CYP1A2 (0.43) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| SCHEMBL5690665 | 0.88 | LMNA (0.41) | CHRM1CHRM3CHRM2SMN1; SMN2CA1 | |
| Ammonia Solution, Strong SCHEMBL27752712 | 0.88 | CYP1A2 (0.43) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| Acetylcholine SCHEMBL14840380 | 0.86 | CHRM1 (0.58) | CHRM1CHRM3CHRM5CHRM2CHRM4 | |
| SCHEMBL9785969 | 0.85 | LMNA (0.38) | CHRM1CHRM3CHRM5SMN1; SMN2CA1 | |
| SCHEMBL9144657 | 0.85 | LMNA (0.41) | CHRM1CHRM3CHRM5CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3143098-B1 | POLYMER AND SURFACTANT COMPOSITIONS AND THEIR USES FOR THE IMPROVED RECOVERY OF HYDROCARBONS | TOTAL SE (FR) | 2021-02-10 | — | — | EP | claimed |
| US-7968083-B2 | Methods of manufacturing deodorants, and deodorants resulting thereof | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2011-06-28 | — | — | US | claimed |
| US-20050232880-A1 | Methods of manufacturing deodorants, and deodorants resulting thereof | HONG KONG POLYTECHNIC UNIVERSITY, THE (CN) | 2005-10-20 | — | — | US | claimed |
| US-6001549-A | IMAGING ELEMENT CONTAINING ANTISTATIC AGENT | EASTMAN KODAK COMPANY (US) | 1999-12-14 | — | — | US | claimed |
| EP-0119713-B1 | LIQUID ELECTROGRAPHIC DEVELOPERS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-10-07 | — | — | EP | claimed |
| US-4547449-A | IMPROVED REPLENISHABILITY | EASTMAN KODAK COMPANY (US) | 1985-10-15 | — | — | US | claimed |
| EP-0119713-A1 | Liquid electrographic developers | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-09-26 | — | — | EP | claimed |
| US-20260056485-A1 | TONER AND IMAGE FORMING METHOD | ZEON CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| EP-4675362-A1 | TONER SET | Zeon Corporation (JP) | 2026-01-07 | — | — | EP | disclosed |
| EP-4675361-A1 | TONER SET AND MAGENTA TONER | Zeon Corporation (JP) | 2026-01-07 | — | — | EP | disclosed |
| EP-4582875-A1 | TONER AND IMAGE FORMING METHOD | Zeon Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-119856121-A | Toner and image forming method | 日本瑞翁株式会社 | 2025-04-18 | — | — | CN | disclosed |
| EP-3730307-B1 | PLANOGRAPHIC PRINTING PLATE PRECURSOR AND PRODUCTION METHOD FOR PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORP (JP) | 2024-10-23 | — | — | EP | disclosed |
| EP-0042307-A2 | An optical recording element and a method of recording information using the element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-12-23 | — | — | EP | disclosed |
| US-4273849-A | HALOGENATED POLYMER, ACRYLIC COPOLYMER | EASTMAN KODAK COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| US-4229513-A | CHLORINATED POLYETHYLENE, AND COPOLYMER OF POLAR MONOMER AND SOLUBILIZING MONOMER | EASTMAN KODAK COMPANY (US) | 1980-10-21 | — | — | US | disclosed |
| US-4166093-A | REDUCTION OF DETECTABLE SPECIES MIGRATION IN ELEMENTS FOR THE ANALYSIS OF LIQUIDS | EASTMAN KODAK COMPANY (US) | 1979-08-28 | — | — | US | disclosed |
| EP-0000247-A1 | Water-absorbent starch copolymerisates and method for their preparation. | A.E. STALEY MANUFACTURING COMPANY (US) | 1979-01-10 | — | — | EP | disclosed |
| US-4133687-A | Photographic elements having hydrophilic colloid layers containing compounds having activator precursors and hydrophobic developing agents uniformly loaded in latex polymer particles | EASTMAN KODAK COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4115332-A | Water-absorbent starch copolymerizates | A. E. STALEY MANUFACTURING COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260056485-A1 | TONER AND IMAGE FORMING METHOD | ACTR5, COG1, COG4 | CHRM1 898/4885CHRM3 1737/4885CHRM5 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.